Glaxosmithkline | GSK - 资产



金融业
股票价格
GBP
资产
GBP 62.87B
现金及等价物
GBP 3.44B
销售成本
GBP 1.88B
流动资产
GBP 17.76B
流动负债
GBP 22.43B
债务
GBP 19.06B
股息收益率
GBP 4.47
EBIT
GBP 2.31B
EBITDA
GBP 2.77B
员工
GBP 69.4K
EPS每股收益
GBP 0.62
股本和储备
GBP 17.42B
销售毛利
GBP 5.75B
债务利息支出
GBP 192.73M
利息收入
GBP 22M
贷款资金
GBP 18.53B
市值
GBP 108.55B
净收入
GBP 1.74B
营业费用
GBP 5.34B
营业利润
GBP 2.29B
普通股股本
GBP 4.05B
PE价格收益
15.09
税前利润
GBP 2.14B
销售收入
GBP 10.09B
销售和管理费用
GBP 2.12B
股票
GBP 6.16B
贸易债权人
GBP 14.34B
应收帐款人
GBP 10.49B


资产 更改 日
AbbVie USD 136.46B 2.5B 2026-03
Amgen USD 92.5B 1.92B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Bausch Health Companies USD 24.5B 1.87B 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Canopy Growth CAD 1.12B 12.54M 2026-03
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Drreddys Laboratories INR 579.35B 573.08B 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Glaxosmithkline GBP 62.87B 19.47B 2026-03
J&J USD 200.89B 1.68B 2026-03
Merck USD 128.68B 8.18B 2026-03
Novartis USD 118.53B 7.58B 2026-03
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Pfizer USD 207.62B 542M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 3.49B 430K 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
Takeda JPY 15.45T 44.34B 2026-03
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03
Zoetis USD 15.15B 313M 2026-03